Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Sankyo reveals potential immunosupressants

July 12, 1996

Immunosuppressive and antiinflammatory agents from Italfarmaco

July 12, 1996

Dacliximab receives patent protection in U.S.

July 5, 1996

Pfizer's CJ-12798 claimed as immunosuppressant, antifungal and antitumor agent

July 5, 1996

MedImmune Lyme disease vaccine shows superior activity in animals

July 5, 1996

Immunostimulants claimed by Italfarmaco

July 5, 1996

PT-11061 reported by Isis

June 28, 1996

AlloMune undergoes clinical research

June 28, 1996

Anergen issued European patent on AnergiX compounds

June 21, 1996

Antibody production-enhancing peptides described

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...